Partenaires
they trust us
“BIOPHACT provided us with a Target Product Profile for our lead compound. We were impressed by the quality of the work and by the quick scientific understand BIOPHACT gathered in a very short time.
The work was highly appreciated by us and our supervisory board. It even delivered now avenues for further indications.
I would highly recommend BIOPHACT without any hesitation.”
Alexander Scheer, PhD
Chief Scientific Officer and Director
“New ways to care For 60 years, we have been innovating relentlessly to take care of everyone“
“We develop new targeted therapies in Cancer « First in Class » & « Best in Class » Protein Disulfide Isomerase inhibitors.
Oregon’s objective is to take this new Drug Candidate into Clinical Development
We were really satisfied by the work Biophact did and we strongly recommend them for their expertise in developing new drugs.”
Dr MH Pitty, MD, CEO
Dr. Coline Leghay, Health Project Manager
Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases
“Biophact supports our students in the Chemistry-Health Master's program by providing them each year with unique insights into therapeutic advances in oncology.”
Dr. Cécile DEHOUX, MCF Responsable master 1 chimie-santé
"Aché LaboratóriosFarmacêuticos collaborated with Biophact under a consulting service model to support the evaluation and strategic recommendation of one of its projects currently at the preclinical stage. This partnership highlights Aché’s commitment to scientific excellence and innovation, relying on Biophact’s expertise to guide key decisions in early-stage development. We recommend Biophact for their deep knowledge and experience in drug development"
Dr Alessandra Mascarello - Research, Development and Innovation.
“We asked Biophact to help us better define our commercialization strategy for an invention that came out of academic research in Bordeaux. Even though the project wasn't very far along, Biophact gave us useful and comprehensive feedback, which helped us see the next steps more clearly.”
Dr Agathe BOULANGE- Cheffe de projet santé et Biotechnologies
“Our support for innovative DeepTech projects is embodied at the Orléans Technology Park by an incubator called the “TT Booster.” We rely on industry experts such as Biophact.
The experience and expertise of Mr. Thierry Clerc, founder and CEO of Biophact, is key to our pharmaceutical development strategy and the design of our clinical and regulatory positioning.”
Mme Alexandra Hugnot- Responsable de Pôle- Chargée de mission innovation
"Nous avons fait appel à l’expertise de Biophact et les données générées ainsi que les conseils avisés de T. Clerc, nous ont apporté pleinement satisfaction. La mission confiée a été réalisée avec succès et les supports produits, la pertinence des analyses, sont de très grande qualité."
Mme Delphine PUERTOLAS -Directrice du Pôle Life Tech.